Related by context. All words. (Click for frequent words.) 70 Transformational Medical 69 SparVax ™ 68 Protexia ® 67 HuCAL antibodies 67 SparVax TM 67 rPA anthrax vaccine 66 Anthim 65 RiVax 65 Acute Radiation Syndrome ARS 64 IND submission 64 PSMA ADC 64 CEQ# 64 PLK1 SNALP 64 Protexia R 64 Allovectin 7 64 PentaStaph 63 HHSN#C 63 raxibacumab 63 RiVax ™ 63 Quinvaxem R 63 Valortim 63 UVIDEM 63 recombinant subunit vaccine 63 mertansine 63 Hedgehog antagonist 63 HCV polymerase 63 InterfeRx 63 GRNVAC1 63 IMVAMUNE ® 63 rhMBL 63 Exherin TM 62 Spiegelmer ® 62 HepaGam B 62 inhaled AAT 62 PDE4 inhibitor 62 IMVAMUNE TM 62 NEUMUNE 62 TKM ApoB 62 forodesine 62 PNT# 62 IMVAMUNE R 62 IMA# 62 novel therapeutic antibodies 62 MEK inhibitor 62 Imvamune R 62 Valortim R 62 adecatumumab MT# 62 oral salmon calcitonin 62 ATL# [001] 62 adenoviral vectors 62 volociximab 62 Zalypsis 62 BioThrax R 62 CCR5 mAb 62 Phase #b/#a clinical 62 rxRNA 62 huC# DM4 62 novel peptides 62 GeoVax AIDS vaccine 62 SCIB1 62 ALN TTR 62 trastuzumab DM1 T DM1 62 Ceplene histamine dihydrochloride 62 Unit Dose Budesonide 61 RenaZorb TM 61 HCV protease inhibitor 61 Shire BioChem Inc. 61 systemic RNAi 61 RTP #i 61 SparVax 61 oral prodrug 61 Protectan CBLB# 61 HuMax TAC 61 SURFAXIN 61 acetonide FA 61 GeneICE 61 telaprevir VX 61 cathepsin K inhibitor 61 Proellex TM 61 PF # [002] 61 R#/MEM # 61 H#N# VLP vaccine 61 Qualified Therapeutic Discovery 61 AEOL # 61 Alnylam #x# 61 Government Qualifying Therapeutic 61 ApoB SNALP 61 KNS # 61 ASONEP 61 PNP inhibitor 61 OMNARIS Nasal Spray 61 BrachySil ™ 61 preclinical toxicology 61 midstage trials 61 VivaGel ™ 61 Valortim TM 61 TransVax tm 61 non nucleoside HCV 61 PrevOnco ™ 61 EndoTAG TM 61 JAK2 Inhibitor 61 Urocidin TM 61 Phase 1a clinical 61 targeted radiotherapeutic 61 Aviptadil 61 SynCon 61 developing TB4 61 GeoVax vaccine 61 GLP toxicology studies 61 TOCOSOL Paclitaxel 61 Resten NG 60 OncoVEX 60 ROTARIX 60 Alvesco R 60 MAGE A3 ASCI 60 RhuDex ® 60 JAK3 60 Enhanze 60 GTC recombinant form 60 Phase lll 60 Selective Electrochemical Tumor Ablation 60 Phase Ib study 60 rindopepimut 60 TKM PLK1 60 AVP #D# 60 GVAX ® 60 Plicera 60 ABthrax TM 60 acyclovir Lauriad R 60 Modified Vaccinia Ankara MVA 60 CCX# 60 TLR9 agonists 60 Captisol ® 60 Fentanyl TAIFUN R 60 DermaVir 60 BioMarck 60 immunotherapeutic vaccine 60 Initiates Clinical 60 Soliris eculizumab 60 Phase 2a clinical trials 60 Prodarsan ® 60 CD# CEA 60 prophylactic vaccines 60 HQK 60 VaxImmune 60 Onconase 60 midstage clinical 60 Factor VIIa 60 M Enoxaparin 60 anti CD3 monoclonal 60 drug ISA# 60 StaphVAX R 60 Androxal TM 60 PrevOnco 60 RiVax TM 60 ATL# [002] 60 prophylactic vaccine 60 nucleotide analog 60 Prodarsan R 60 vidofludimus 60 Nanobody R 60 BrachySil TM 60 YONDELIS 60 oral methylnaltrexone 60 PDL# 60 SNALP technology 60 investigational humanized monoclonal antibody 60 PhG alpha 1 60 HEPLISAV ™ 60 telomerase inhibitor drug 60 cMET 60 DispersinB ® 60 CMV vaccine 60 Surfaxin LS 60 Initiates Phase II 60 valopicitabine NM# 60 Loramyc ™ 60 rhLF 60 CIP TRAMADOL ER 60 NIH NIAID 60 Shigamabs ® 60 LentiVector technology 60 MAXY alpha 60 PHX# 59 TRO# 59 candidate REP# 59 antibody MAb 59 Altastaph 59 Increlex TM 59 molecular chaperone regulation 59 MAXY G# 59 mitogen activated ERK kinase 59 Restanza 59 HDL Mimetic Peptide 59 Phase IIb clinical trials 59 Tarvacin TM 59 ALN TTR# 59 GATTEX TM 59 Inotek Pharmaceuticals Corporation 59 ENMD # 59 phase IIb clinical 59 Stimuvax R 59 histone deacetylase HDAC inhibitor 59 Staphylococcus aureus Polysaccharide Conjugate 59 siRNA therapeutics 59 elotuzumab 59 Fx #A 59 BLA filing 59 Emezine 59 MVA BN R 59 ALN PCS 59 Panzem 59 Dacetuzumab 59 siRNA therapeutic 59 Lixivaptan 59 Sym# 59 pafuramidine maleate 59 novel RNAi therapeutics 59 next generation URAT1 59 MAA submission 59 glucokinase activator 59 BioNumerik 59 CRMD# 59 Arzerra ofatumumab 59 synthetic retinoid 59 Cerashield 59 Panzem R 59 therapeutic monoclonal antibody 59 sodium thiosulfate STS 59 SinuNase ™ 59 preclinical 59 Nanobody 59 aerosolized AAT 59 Arikace 59 Aurora kinase inhibitor 59 ProMune 59 BiTE antibody 59 AMPAKINE CX# 59 Ceragenin ™ 59 preclinical efficacy 59 SNT MC# 59 Syntonix 59 ASX PGL 59 successfully commercialize Iluvien 59 Oncaspar 59 RNAi Therapeutic 59 therapeutic monoclonal antibodies 59 Fibrillex TM 59 Kosan dependence 59 Lenocta 59 initiated Phase Ib 59 Cand5 59 LymphoStat B TM 59 AAV vector 59 TLR9 agonist 59 SARcode 59 Anidulafungin 59 Civacir 59 Valortim ® 59 ddRNAi 59 Vaxfectin 59 Argatroban 59 StemEx R 59 Biologic License Application BLA 59 Allovectin 7 R 59 Proxinium TM 59 pharmacokinetic PK study 59 alpha#beta# integrin 59 investigational oral hepatitis C 59 JAK inhibitor 59 Iluvien ® 59 deforolimus 59 Traficet EN 59 BioThrax ® 59 recombinant protective 59 brivaracetam 59 DPX Survivac 59 Diamyd ® 59 VersaFilm 59 faropenem 59 Development Authority BARDA 59 lumiliximab 59 phase IIa clinical 59 XOMA 3AB 59 Project QTDP 59 Hedgehog pathway inhibitor 58 CBLB# 58 registrational studies 58 EHT AGN 58 ATryn ® 58 Actimmune ® 58 HuMax EGFr 58 OvaRex R 58 eniluracil 58 proprietary PEGylation 58 Phase #/#a 58 huN# DM1 58 DiLA2 58 ADVANCE PD 58 lipid nanoparticle 58 MT#/MEDI-# 58 Rotarix R 58 BUPHENYL R 58 Shigamabs R 58 IL# PE#QQR 58 Bellicum 58 HspE7 58 topical ophthalmic 58 Japanese Encephalitis Vaccine 58 Etubics 58 Veronate 58 Dacogen injection 58 IMVAMUNE 58 HuLuc# 58 Maxy G# 58 Virulizin 58 Junovan TM 58 Imvamune 58 phase Ib clinical 58 Elusys 58 CVac 58 nalbuphine ER 58 Hexvix ® 58 telomerase therapeutic 58 NovaBay Aganocide compounds 58 anticancer compound 58 candidate ATHX 58 lucinactant 58 Harry Palmin President 58 OTCBB HXBM developer 58 Cytolin 58 Completes Patient Enrollment 58 HepDirect prodrug 58 Zemiva TM 58 CGEN # 58 Flutiform ™ 58 Medical Countermeasure 58 BCR ABL inhibitor 58 AERx iDMS 58 PRT# 58 Zor Pharmaceuticals 58 MorphoSys proprietary 58 hGH CTP 58 Somatuline Depot 58 Alzhemed TM 58 pDNA vaccine 58 lead Aganocide compound 58 TransVax ™ 58 Loramyc TM 58 Hepavax Gene ® 58 Initiates Enrollment 58 virus HCV protease inhibitor 58 torezolid phosphate 58 atacicept 58 liver resection surgeries 58 Presents Preclinical Data 58 menadione 58 Phase Ib II 58 NanoTab 58 Davanat 58 targeting PCSK9 58 CytoFabTM 58 Exploratory IND 58 GRN# 58 ARIKACE 58 tafamidis 58 methylnaltrexone 58 EPA ToxCast 58 IAP inhibitor 58 HGS# 58 tramiprosate ALZHEMED TM 58 PDE# inhibitors 58 TBC# 58 OMP #R# 58 human IgG1 monoclonal 58 SBIR Phase III 58 riociguat 58 novel histone deacetylase 58 PROCHYMAL 58 FluINsure 58 non nucleoside inhibitor 58 Virulizin R 58 SBIR grant 58 MGd 58 ROTATEQ 58 PREOS R 58 Anticalin R 58 Fodosine 58 Submits Response 58 lomitapide 58 E1 INT TM 58 monoclonal antibody mAb 58 JAK2 inhibitor 58 Bellicum Pharmaceuticals Inc. 58 AZX# 58 Bioral Amphotericin B 58 multicenter Phase II 58 Orphan Drug designations 58 reslizumab 58 Troxatyl TM 58 Onco TCS 58 Cloretazine ® 58 CytoFab 58 PEGylated interferon 58 HuMax HepC TM 58 generation URAT1 inhibitor 58 CFFT 58 MAXY VII 58 apricitabine ATC 58 pradefovir 58 License Option Agreement 58 NeuroSolutions 58 rALLy clinical trial 58 Cethromycin 58 eligen 58 VitiGam 58 THALOMID 58 RAPTIVA R 58 Glassia 58 Cerashield ™ 58 5 HT3 antagonist 58 Galenea 58 rThrombin 58 orally administered inhibitor 58 Zenvia ™ 58 Liprotamase 58 miRNA therapeutics 58 Aganocide 58 RECOTHROM ® 58 Nasdaq HALO 58 Awarded Qualifying Therapeutic 58 ELACYT 58 adrenergic regulation 58 IMPACT DCM clinical 58 BLP# Liposome Vaccine 57 Hiberix 57 Somatuline R Autogel R 57 Phase Ib clinical 57 CBLC# 57 NASDAQ CGEN announced 57 Potelligent Technology 57 HCV polymerase inhibitor 57 TRX1 57 TYZEKA 57 molecular imaging radiopharmaceutical 57 CAMPATH 57 ATL/TV# 57 AEG# 57 rPA 57 humanized monoclonal antibodies 57 CIMZIA TM 57 TRISENOX ® 57 TransVax TM 57 HGS ETR1 mapatumumab 57 hepatitis B immune globulin 57 Voraxaze 57 Vernakalant 57 phosphatidylserine PS targeting 57 Medidur FA 57 anthrax monoclonal antibody 57 Prestara 57 Neo Kidney Augment ™ 57 EP #R 57 Phase III confirmatory 57 ORE# 57 Aurexis 57 EGS# 57 oncolytic virus 57 Zidovudine Tablets 57 Scancell 57 Lisofylline LSF 57 vaginally administered lidocaine 57 Ganite ® 57 BRILINTA 57 depsipeptide 57 InterfeRx TM 57 BEXXAR 57 Saforis 57 PEGylated 57 Empatic ™ 57 miconazole Lauriad R 57 TransMID 57 HepeX B 57 GED aPC 57 brivanib 57 Integrated Preclinical 57 Relivar 57 Ampligen r 57 SinuNase TM 57 HTS assay 57 polymerase inhibitor 57 Amigal 57 RNA interference RNAi therapeutics 57 Tarceva TM 57 pDNA vaccines 57 Vicinium TM 57 arsenic trioxide injection 57 LUCASSIN 57 Vaxfectin R formulated 57 DXL# 57 Phase 1b clinical trials 57 Hematide ™ 57 JZP 57 novel antiviral therapeutics 57 Vaxfectin R adjuvant 57 HDL Selective Delipidation 57 TELINTRA 57 Allovectin 7 r 57 Nasdaq VICL 57 TLK# 57 celgosivir 57 EndoTAG TM -1 57 candidate deforolimus 57 Dacogen decitabine 57 Inhalation Solution 57 Cutanea 57 Maribavir 57 ALN VSP Phase 57 AAG geldanamycin analog 57 iroxanadine 57 PEG SN# 57 supplemental biologics 57 Nasdaq PPHM 57 Rhucin ® recombinant 57 outlicensing 57 CCR9 antagonist 57 oral dihydropyrimidine dehydrogenase DPD 57 product platforms AZX# 57 entity NCE 57 fostamatinib 57 recombinant polyclonal antibody 57 dacetuzumab 57 HBV vaccine 57 #D#C# 57 Targeted Chemotherapy 57 GLP toxicology 57 highly selective adenosine 57 DOS# 57 Allovectin 7 ® 57 receptor tyrosine kinase inhibitor 57 Neugene 57 TIGER biosensor system 57 pafuramidine 57 RhuDex R 57 RANK Ligand inhibitor 57 G#DT 57 fostamatinib disodium 57 IRX 2 57 Submits IND 57 Avid Bioservices 57 inhibit oxidative stress 57 MPL adjuvant 57 AN# novel 57 Successfully Completes Phase 57 tremelimumab 57 NIAID NIH 57 TKB# 57 ALN VSP 57 NeuVax 57 Alferon N 57 Anticalin ® 57 murine monoclonal antibody 57 RNAi therapeutic targeting 57 Phase IIa trials 57 Oncotype DX colon cancer 57 Proquin XR 57 Ampligen ® 57 rBChE 57 ImmunoVEX HSV2 57 Nanobody ® 57 Genasense ® oblimersen 57 investigational smallpox vaccine 57 Eniluracil 57 ZFP Therapeutics 57 Fresenius Biotech 57 Xcytrin R 57 ImmunoGen TAP technology 57 AeroLEF TM 57 ESTRASORB R 57 daptomycin 57 DEB# 57 Guanilib 57 OHR/AVR# 57 IND enabling 57 ridaforolimus 57 AMPK activators 57 siRNAs targeting 57 Phase Ib IIa 57 Onalta 57 alvespimycin 57 Nasdaq VRTX 57 Phase III ADT 57 Biological License Application 57 HCV nucleoside polymerase inhibitors 57 systemic RNAi therapeutic 57 cellular immunotherapy 57 Genasense oblimersen sodium Injection 57 Ibis T# Biosensor System 57 drug conjugate 57 oral PTH 57 ALN HTT 57 PORxin TM platforms 57 intranasal formulation 57 Mepact 57 Tarmogen 57 ImQuest 57 IIa trial 57 Restanza TM 57 CRD5 57 Vegenics 57 QLT# 57 Aurograb 57 WHO prequalification 57 Rhucin R 57 NP2 Enkephalin 57 cinacalcet HCl 57 Phase IIb III 57 Ceflatonin ® 57 preclinically 57 agonistic human 57 Phase IIa clinical trials 57 Chrysalin 57 LymphoStat B belimumab 57 DAIDS 57 PFO migraine 57 ADP receptor antagonist 57 FOLOTYN ® 57 CRLX# 57 VivaGel TM 57 LGLS 57 Fast Track Status 57 Solazed 57 Velcade bortezomib 57 Troxatyl 57 intradermal injections 57 SAR# [004] 57 L BLP# 57 EpiTherapeutics 57 EV# vaccine 57 nicotinic alpha 7 57 Hsp# Inhibitor 57 Crofelemer budesonide foam 57 ENZON 57 OncoVEX GM CSF 57 anticancer therapeutics 57 CINTREDEKIN BESUDOTOX 57 mda 7 57 RAPTIVA 57 Virosome Biologicals 57 Ascend Therapeutics 57 BioGeneriX 57 radiolabeled monoclonal antibody 57 docetaxel Taxotere R 57 Phase Ib clinical trials 57 budesonide foam 57 lintuzumab SGN 57 including eniluracil ADH 57 compound PMX # 57 Onalta ™ 57 Neo Kidney Augment 57 HGS ETR2 57 LNP formulations 57 Dalbavancin 57 NASDAQ PGNX 56 EndoBiologics 56 pharmacological chaperone 56 Trofex 56 CCR1 56 TASKi3 56 polysaccharide polymer 56 BLA submission 56 liposomal formulation 56 sitaxsentan 56 candidate XP# 56 OncoVex 56 EVIZON TM squalamine lactate 56 Lucanix R 56 HepeX B TM 56 immune modulatory 56 microtubule inhibitor 56 Vaxfectin TM 56 tiapamil 56 Tiuxetan 56 PTH1 56 Hedgehog agonist 56 PATH Malaria Vaccine Initiative 56 PANVAC VF 56 STEDESA 56 Cethrin 56 confirmatory Phase III 56 anti botulism antibody 56 Phase #b/#a 56 Quinvaxem TM 56 BioVant 56 Onrigin 56 Myrexis 56 GVAX R 56 SynCon ™ DNA 56 protein tyrosine phosphatase 1B 56 Sulonex TM 56 interferon gamma 1b 56 small molecule thrombopoietin 56 ISTODAX 56 Azedra 56 Familial Adenomatous Polyposis FAP 56 radiotherapeutic 56 MORAb 56 oncolytic 56 Nasdaq PGNX today 56 Primera Bioscience 56 Nanotechnology Characterization Laboratory 56 phase Ib 56 GeoVax HIV AIDS 56 BrachySil 56 CCR5 antagonist 56 Valtropin 56 Aganocide ® 56 phase IIa 56 XmAb 56 Ceplene ® histamine dihydrochloride 56 RIGScan CR 56 Gamunex C 56 investigational hepatitis B 56 R#/MEM 56 ONCONASE R 56 Cumulase 56 Zemplar Capsules 56 Actimmune R 56 Curaxin 56 4SC AG ISIN DE# 56 Bezielle 56 subcutaneous formulation 56 oral antiviral 56 MOVIPREP R 56 SNALP 56 Prosaptide 56 Bioral 56 Initiate Clinical Trial 56 vinorelbine tartrate 56 Development OOPD 56 POSIDUR TM 56 incyclinide 56 recombinant hepatitis B 56 elacytarabine 56 Mpex 56 Capesaris 56 immunotherapeutics 56 Anturol ® 56 PORxin TM 56 StemEx 56 aurora kinase 56 DepoVax TM 56 recombinant biopharmaceutical 56 Taiho Pharmaceutical 56 Vitaxin 56 MKC# MT 56 XmAb ® 56 KRYSTEXXA TM pegloticase 56 Taligen Therapeutics 56 Neumune 56 SBIR Phase 56 Morpholino 56 Ethyol 56 opioid induced bowel dysfunction 56 Synerx 56 vosaroxin 56 chimeric monoclonal antibody 56 ARIKACE ™ 56 Litx 56 NTDDS 56 LHRH antagonist 56 GALNS 56 Zevalin R Ibritumomab 56 Project QTDP program 56 Lung Rx 56 docetaxel Taxotere ® 56 NYSE Amex HEB 56 Pafuramidine 56 Loramyc R 56 Aphthasol R 56 Cloretazine 56 Sudhir Agrawal D.Phil 56 Neovasc Reducer 56 Crofelemer 56 Reports Preclinical Data 56 IRS Qualifying Therapeutic 56 PGL# 56 vapreotide acetate 56 EVIZON TM 56 novel peptide 56 optimal dosing regimens 56 SNS# T 56 Flutiform TM 56 Oasmia 56 Tß4 56 Orphan Drug status 56 miconazole Lauriad ® 56 Tectin TM 56 AIMM trial 56 UPLYSO 56 Ridaforolimus 56 Ganciclovir 56 Tyzeka Sebivo 56 synthetic peptide containing 56 Survivin antagonist 56 TYGACIL 56 please visit http:/www.sunesis.com 56 HepaGam B TM 56 OvaRex ® MAb 56 immunotoxins 56 modified vaccinia Ankara 56 Receives Milestone Payment 56 OMAPRO ™ 56 acyclovir Lauriad ® 56 hormone LHRH antagonist 56 fully liquid pentavalent 56 Syntiron 56 GTC recombinant human 56 NASDAQ ARRY 56 rADTZ 56 humanized monoclonal 56 Curaxin CBLC# 56 PI3K/Akt pathway inhibitor 56 HCV NS5B polymerase 56 ALTROPANE R 56 OMNARIS HFA 56 antiviral therapeutics 56 Inc. Nasdaq PPHM 56 P#X# antagonist 56 cGMP manufacture 56 ZaBeCor 56 biotherapeutic drugs 56 Asentar TM 56 TORISEL 56 HepaMate 56 HHS BARDA 56 Tumour Vascular Disrupting Agent 56 catalytic antioxidant compounds 56 MOZOBIL 56 Targretin capsules 56 recombinant Factor 56 Nasdaq OMER 56 rhFVIIa 56 TSX SHQ 56 TRAIL receptor antibodies 56 CORT # 56 diagnostic radiopharmaceutical 56 CALGB # [002] 56 Septin 9 56 highly purified pasteurized 56 Oncobionic 56 Ketotransdel 56 ImmunoCellular Therapeutics 56 GW# [003] 56 GRAS notification 56 Chimigen TM 56 Kyowa Kirin 56 JAK inhibitors 56 BCR ABL inhibitors 56 inhaled liposomal ciprofloxacin 56 plasmid DNA pDNA 56 HCV nucleotide polymerase inhibitor 56 DepoVax 56 Dacogen TM 56 AMEX RGN 56 Trubion Pharma 56 ARRY # 56 JAK1 56 tkRNAi 56 Creabilis Therapeutics 56 Nexavar sorafenib 56 GlaxoSmithKline Biologicals GSK 56 VitiGam TM 56 AERx ® 56 TIMERx 56 Daclizumab 56 R roscovitine 56 faropenem medoxomil 56 autologous cellular immunotherapy 56 sNDA submission 56 please visit www.advaxis.com 56 Kahalalide F 56 Phase III TRIST 56 investigational protease inhibitor 56 THR beta agonist 56 preclinical studies 56 Cellegesic 56 CIMZIA ™ 56 ZFP Therapeutic 56 RNAi therapeutic 56 HDAC Inhibitor 56 Anturol TM 56 Ozarelix 56 biodefense countermeasure 56 Neogenix 56 Montigen 56 Urocidin 56 Transgene therapeutic 56 Cyclosert TM 56 Achieves Primary Endpoint 56 Nabi HB Intravenous 56 HCV protease inhibitors 56 topical anti infective 56 POTELLIGENT R Technology 56 ThermoDox ® clinical 56 KSP inhibitor 56 Prochymal TM 56 humanized monoclonal antibody 56 trodusquemine 56 Fabry Disease 56 MYDICAR ® 56 synDNA TM 56 Optiquel ™ 56 Belerofon 56 HuMax CD4 56 biologic therapeutics 56 dutogliptin 56 oral taxane 56 Caprion 56 HepDirect 56 refractory chronic lymphocytic 56 ZOLINZA 56 HCD# [002] 56 AGTC 56 oral talactoferrin 56 WILEX 56 Vascular Disrupting Agent 56 OXi# 56 ongoing Phase 1b 56 Synagis palivizumab 56 HEPLISAV TM 56 Urokinase 56 Nascobal ® 56 targeted antifolate 56 Bicifadine 56 Albugon 56 Triapine 56 thiazolides 56 Initiate Phase 56 Actilon 56 SPL# Gel vaginal microbicide 56 CALAA 56 ONCASPAR 56 Granted Orphan Drug 56 Prodarsan 56 ENTOCORT EC 56 Receive Milestone Payment 56 CD# monoclonal antibody 56 Intravail R 56 Personalized Immunotherapy 56 PLX cells 56 ATryn R 56 rilonacept 55 Ostarine ™ 55 Rotarix ® 55 ACAM# 55 delivers fluocinolone acetonide FA 55 markets Testim ® 55 botulism antitoxin 55 SBIR Grant 55 NPC 1C 55 ORENCIA R 55 NVA# 55 ORMD 55 Liposomal 55 novel antibody therapeutics 55 Pimavanserin 55 histone deacetylase HDAC 55 oral JAK1 55 XP# XP# 55 ANAVEX #-# [001] 55 Kevetrin ™ 55 pivotal bioequivalence 55 Ampligen R 55 systemically administered 55 OxBC 55 DP VPA 55 RNAi Therapeutics 55 Omacetaxine 55 Japanese Encephalitis vaccine 55 EXPLORE Xa 55 oral ridaforolimus 55 PharmaNova 55 solithromycin 55 Ceflatonin R 55 Mucosal 55 lexidronam injection 55 MyVax ® 55 Alfacell proprietary ribonuclease 55 Serdolect ® 55 oncolytic virus therapy 55 Surfaxin lucinactant 55 investigational monoclonal antibody 55 commercialize AzaSite 55 XL# XL# 55 IGF 1R inhibitor 55 proteasome inhibitor 55 RECOTHROM R 55 bortezomib Velcade